Sbir solicitation no. PHS 2020-1 topic #408: tools and technologies for visualizing multi-scale data project title: an imagedx based multi-scale platform for tissue, cellular, molecular, and genomic…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91020C00012
- Awardee
-
Reveal Biosciences Inc. UEI HEEAZ9FXXM13
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $386,940
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $386,940.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $386,940 |
About this award
This contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Reveal Biosciences Inc., a small disadvantaged business based in San Diego, CA. The $386,940 firm-fixed-price contract was issued under a Small Business Innovation Research (SBIR) solicitation focused on developing "Tools and Technologies for Visualizing Multi-Scale Data" to support cancer research and prevention efforts. Reveal Biosciences specializes in computational pathology and AI-enabled imaging platforms, and has received prior SBIR and other federal contracts from HHS agencies to advance their tissue analysis and cancer imaging capabilities. This award aligns with the NCI's mission to leverage innovative technologies like AI and advanced visualization to improve cancer diagnosis, treatment, and outcomes.
Description
Sbir solicitation no. PHS 2020-1 topic #408: tools and technologies for visualizing multi-scale data project title: an imagedx based multi-scale platform for tissue, cellular, molecular, and genomic visualization.
Quick answers
Who was awarded contract 75N91020C00012?
75N91020C00012 was awarded to Reveal Biosciences Inc. by National Cancer Institute (National Institutes of Health) on August 24, 2020.
How much is contract 75N91020C00012 worth?
The government has obligated $386,940 on 75N91020C00012.
Was contract 75N91020C00012 competed?
The extent of competition for 75N91020C00012 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award